Source: Annual Congress 2002 - COPD: from molecules to man
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Qiu, J. Zhu, V. Bandi, A. E. Fraire, K. K. Guntupalli, P. K. Jeffery (London, United Kingdom; Houston, Worchester, United States Of America). Reticular basement membrane (RBM) thickness, neutrophils and eosinophils in severe exacerbations of COPD and asthma. Eur Respir J 2002; 20: Suppl. 38, 1407

Member's Comments

No comment yet.

Related content which might interest you: Noneosinophilic asthma in children: relation with airway remodelling Source: Eur Respir J 2011; 38: 575-583 Year: 2011 Anti-IgE and airway remodelling: Omalizumab affects reticular basement membrane thickness in severe persistent atopic asthma Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD Year: 2011 COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Inflammatory cell activation in eosinophilic and non-eosinophilic asthma Source: Annual Congress 2006 - Immunology of the airways Year: 2006 Outgrown asthma does not mean no airways inflammation Source: Eur Respir J 2002; 19: 284-287 Year: 2002 Osteopontin expression and relation to disease severity in human asthma Source: Eur Respir J 2011; 37: 331 Year: 2011 Corticosteroid sensitivity, persistent airflow limitation and basement membrane thickening in children with asthma Source: Annual Congress 2008 - Treatment and outcome of childhood asthma: new perspectives Year: 2008 Increased circulating alveolar epithelial microparticles in COPD patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Small airway reticular basement membrane (Rbm) thickening in clinically stable lung transplant recipients (SLTR) is not affected by three months treatment with inhaled corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 347s Year: 2002 Characteristics of eosinophilic and neutrophilic inflammation of bronchi of the bronchial asthma (BA) patients Source: Eur Respir J 2001; 18: Suppl. 33, 32s Year: 2001 Effects of a 12-month course with omalizumab on basement membrane thickness in severe persistent atopic asthma Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Basement membrane thickness, eosinophilic inflammation and urinary LTE4 in patients with nasal polyps with or without bronchial asthma Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients Year: 2007 Eosinophilopoietins receptors, TGF-ß1 and outer-membrane integrins expression of lung-resident and inflammatory eosinophils in severe non-allergic eosinophilic asthma Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma Year: 2019 Parameters associated with persistent airflow obstruction in chronic severe asthma Source: Eur Respir J 2004; 24: 122-128 Year: 2004 Fibrocyte accumulation in the airway walls of COPD patients Source: Eur Respir J, 54 (3) 1802173; 10.1183/13993003.02173-2018 Year: 2019 Subepithelial basement membrane thickness in bronchial asthma assessed by bronchoscopy Source: Eur Respir J 2005; 26: Suppl. 49, 118s Year: 2005 The importance of eosinophilic inflammation in COPD exacerbations Source: International Congress 2017 – COPD management Year: 2017 Basement membrane, eosinophilic inflammation and urinary LTE4 in cough variant asthma and GER-induced chronic cough Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010 Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial Source: Eur Respir J 2007; 29: 906-913 Year: 2007 Altered composition of airway basement membranes in COPD Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011